Чучалин пневмонии рекомендации


Пневмония: актуальная проблема медицины ХХΙ века | Чучалин

1. ​Rozenbaum M.H., Pechlivanoglou P., van der Werf T.S.et al. The role of Streptococcus pneumoniae in community-acquired pneumonia among adults: a meta-analysis. Eur. J. Clin. Microb. Infect. Dis. 2013, 32: 305–316.

2. ​Sinclair A., Xie X., Teltscher M., Dendukuri N. Systematic review and meta-analysis of urine pneumococcal antigen test for diagnosis of community-acquired pneumonia caused by Streptococcus pneumoniae. J. Clin. Microbiol. 2013; 51 (7): 2303–2310.

3. ​Horita N., Miyazawa N., Kojima R.et al. Sensetivity and specificity of the S. pneumoniae urinary antigen test for unconcentrated urine from adult patients with pneumonia: a meta-analysis. Respirology. 2013; 18: 1177–1183.

4. ​Biondi E., McCulloh R., Alverson B. et al. Treatment of Mycoplasma pneumoniae: a systematic review. Pediatrics. 2014; 133 (6): 1081–1090.

5. ​Chalmers J.D., Rother C., Salih W., Ewig S. Healthcare-associated pneumonia does not accurately identify potentially resistant pathogen: a meta-analysis. Clin. Infect. Dis. 2014, 58: 330–339.

6. ​Troltino A.S., Porhomayon J., El-Solh A.A. Guideline-concordant antimicrobial therapy for healthcare-associated pneumonia: a systematic review and meta-analysis. Lung. 2013; 191: 229–237.

7. ​Phung D.T., Wang Z., Rutherford S. et al. Body mass index and risk of pneumonia: a systematic review meta-analysis. Obesity Rev. 2013; 14: 839–857.

8. ​Nie W., Zhang Y., Jee S.H. et al. Obesity survival paradox in pneumonia: a meta-analysis. BCM Med. 2014; 12: 61.

9. ​Mannu G.S., Loke Y.K., Curtain J.P. et al. Prognosis of multi-lobar pneumonia in community-acquired pneumoniae: a meta-analysis. Eur. J. Inter. Med. 2013; 24 (8): 857–863.

10. ​Li L., Nie W., Li W. et al. Associations between TNF-#a polymorphisms and pneumonia: a meta-analysis. PloS One. 2013; 8 (4): e61039.

11. ​Loke Y.K., Kwok C.S., Wong J.M. et al. Chronic obstructive pulmonary disease and mortality from pneumonia: a meta-analysis. Int. J. Clin. Pract. 2013; 67 (5): 477–487.

12. ​Salih W., Schembri S., Chalmers J.D. Simplification of the IDSA / ATS criteria for severe CAP using meta-analysis. Eur. Respir. J. 2014; 43 (3): 842–851.

13. ​Zachary W., Fitch M.S., Glenn J.R. Whitman: Incidence, risk, prevention ventilator-associated pneumonia in adult cardiac surgical patients: a systematic review. J. Card. Surg. 2014; 29 (2): 196–203.

14. ​Gu W.-J., Wang F., Tang L. et al. Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: a meta-analysis. Inter. J. Antimicrob. Agents. 2014; 44: 477–485.

15. ​Dimopolous G., Poulakou G., Pneumatikos I.A. et al. Short vs long-duration antibiotic regimens for ventilator-associated pneumonia: a meta-analysis. Chest. 2013; 144 (6): 1759–1767.

16. ​Miller A.E., Punt N., Mouton J.W. Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia. J. Antimicrob. Chemother. 2013; 68 (4): 900–906.

17. ​Kalil A.C., Klompas M., Haynatzki G., Rupp M.E. Treatment of hospital-acquired pneumonia with linisolid or vancomycin: a meta-analysis. BMJ Open. 2013; 3: e003912.

18. ​Jiang H., Tang R.-N., Wang J. Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a meta-analysis. Eur .J. Clin. Microb. Infect. Dis. 2013, 32: 1121–1128.

19. ​Melsen W.G., Rovers M.M., Groenwold R.H. et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet. Infect. Dis. 2013; 13: 665–671.

20. ​Silvestri L., Weir I., Gregori D. et al. Effectiveness of oral chlorhexidine on nosocomial pneumonia, causative micro-organisms and mortality in critically ill patients: a meta-analysis. Minerva Anestesiol. 2014; 80 (7): 805–820.

21. ​Nie W., Lit B., Xio Q. #b-Lactam/macrolid dual therapy versus #b-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis. J. Antimicrob. Chemother. 2014; 69: 1441–1446.

22. ​Skalsky K., Yahav D., Lador A.et al. Macrolides vs quinolones for community-acquired pneumonia: a meta-analysis. Clin. Microb. Infect. 2013; 19: 370–378.

23. ​Ginsburg A.S., Tinkham L., Riley K. et al. Antibiotic non-susceptibility among Streptococcus pneumoniae and Haemophilus influenzae isolates identified in African cohorts: a meta-analysis. Int. J. Antimicrob. Agents. 2013; 42 (6): 482–491.

24. ​Cheng M., Pan Z.-Y., Yang J., Gao Y.-D. Corticosteroid therapy for severe community-acquired pneumonia: a meta-analysis. Respir. Care. 2014; 59 (4): 557–563.

25. ​Shafiq M., Mansoor M.S., Khan A.A. et al. Adjuvant steroid therapy in community-acquired pneumonia: a systematic review and meta-analysis. J. Hosp. Med. 2013; 8 (2): 68–75.

26. ​Confalonieri N., Annane D., Antonaglia C. et al. Is prolonged low-dose glucocorticoid treatment beneficial in community-acquired pneumonia? Curr. Infect. Dis. Repir. 2013; 15: 158–166.

27. ​Bo L., Li J., Tao T. et al. Probiotics for preventing ventilator-associated pneumonia. Cochrane Database Syst. Rev. 2014; 10: CD009066.

28. ​Cheng H.-H., Tang T.-T., He Q. et al. Beneficial effects of statins on outcomes in pneumonia: a systematic review and meta-analysis. Eur. Rev. Med. Pharmacol. Sci. 2014; 18 (16): 2294–2305.

29. ​Filion K.B., Chateu D., Targownik L.E.et al. Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis. Gut. 2014, 63: 552–558.

30. ​Nie W., Zang Y., Chen J. et al. Angiotensin-converting enzyme I/D polymorphism with pneumonia risk: a meta-analysis. J. Renin-Angiotensin-Aldosterone Syst. 2014 (Feb. 4).

31. ​Gross A.K., Dunn S.P., Feola D.J. et al. Clopidogrel treatment on the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness. J. Thromb. Thrombolysis. 2013; 35 (2): 147–154.

32. ​Yang M., Yan Y., Yin X. et al. Chest physiotherapy for pneumonia in adults. Cochrane Database Syst. Rev. 2013; 2: CD006338.

33. ​Hemila H., Louhiala P. Vitamin C for preventing and treating pneumonia. Cochrane Database Syst. Rev. 2013; 8: CD005532.

34. ​Chavez M.A., Shams N., Ellingtone L.E. et al. Lung ultrasound for the diagnosis of pneumonia in adults: a systematic review and meta-analysis. Respir. Res. 2014, 15: 50.

35. ​Hu Q.J., Shen Y.C., Jia L.Q. et al. Diagnostic performance of lung ultrasound in the diagnosis of pneumonia a bivariate meta-analysis. Int. J. Clin. Exp. Med. 2014; 7 (1): 115-121.

[PDF] [Пневмония: региональный опыт профилактических программ].

 @article {Chuchalin2016PneumoniaRE, title = {[Пневмония: региональный опыт профилактических программ].}, автор = {Александр Г. Чучалин, Геннадий Г. Онищенко, Виктор П. Колосов, О. П. Курганова, Николай Тезиков, Леонид Г. Манаков, М. П. Гулевич и Ю. М. Перельман}, journal = {Терапевтический архив}, год = {2016}, объем = {88 8}, pages = { 87-92 } } 
AIM Обобщить региональный опыт реализации комплекса организационно-методических и противоэпидемических мероприятий по профилактике пневмококковых инфекций.МАТЕРИАЛ И МЕТОДЫ. Проанализировано, как реализуются профилактические программы с использованием материалов и методов эпидемиологического и статистического мониторинга заболеваемости пневмонией в Амурской области. Пневмококковая конъюгированная вакцина (Превенар-13) и вакцины против гриппа использовались для иммунопрофилактики против острой болезни… ПРОДОЛЖИТЬ ЧТЕНИЕ

Сохранить в библиотеку

Создать оповещение

Cite

Launch Research Feed

.

Современные методы лечения внебольничной пневмонии / 1 номер / 2012